161 related articles for article (PubMed ID: 32807607)
1. Low-Dose Computed Tomography Screening Proposal for the "Big-3 Diseases": Lung Cancer, Chronic Obstructive Pulmonary Disease, and Cardiovascular Disease.
Spinnato P
Acad Radiol; 2021 Jan; 28(1):46-48. PubMed ID: 32807607
[No Abstract] [Full Text] [Related]
2. Screening for Early Lung Cancer, Chronic Obstructive Pulmonary Disease, and Cardiovascular Disease (the Big-3) Using Low-dose Chest Computed Tomography: Current Evidence and Technical Considerations.
Heuvelmans MA; Vonder M; Rook M; Groen HJM; De Bock GH; Xie X; Ijzerman MJ; Vliegenthart R; Oudkerk M
J Thorac Imaging; 2019 May; 34(3):160-169. PubMed ID: 30550403
[TBL] [Abstract][Full Text] [Related]
3. Willingness to participate in combination screening for lung cancer, chronic obstructive pulmonary disease and cardiovascular disease in four European countries.
Behr C; Koffijberg H; IJzerman M; Kauczor HU; Revel MP; Silva M; von Stackelberg O; van Til J; Vliegenthart R
Eur Radiol; 2024 Jul; 34(7):4448-4456. PubMed ID: 38060003
[TBL] [Abstract][Full Text] [Related]
4. Incidental Findings in Lung Cancer Screening: Which Ones are Relevant?
Godoy MCB; Pereira HAC; Carter BW; Wu CC; Erasmus JJ
Semin Roentgenol; 2017 Jul; 52(3):156-160. PubMed ID: 28734397
[No Abstract] [Full Text] [Related]
5. Early imaging biomarkers of lung cancer, COPD and coronary artery disease in the general population: rationale and design of the ImaLife (Imaging in Lifelines) Study.
Xia C; Rook M; Pelgrim GJ; Sidorenkov G; Wisselink HJ; van Bolhuis JN; van Ooijen PMA; Guo J; Oudkerk M; Groen H; van den Berge M; van der Harst P; Dijkstra H; Vonder M; Heuvelmans MA; Dorrius MD; De Deyn PP; de Bock GH; Dotinga A; Vliegenthart R
Eur J Epidemiol; 2020 Jan; 35(1):75-86. PubMed ID: 31016436
[TBL] [Abstract][Full Text] [Related]
6. Computed tomographic screening for lung cancer: an opportunity to evaluate other diseases.
Mets OM; de Jong PA; Prokop M
JAMA; 2012 Oct; 308(14):1433-4. PubMed ID: 23047354
[No Abstract] [Full Text] [Related]
7. Computed Tomography Screening for Early Lung Cancer, COPD and Cardiovascular Disease in Shanghai: Rationale and Design of a Population-based Comparative Study.
Du Y; Li Q; Sidorenkov G; Vonder M; Cai J; de Bock GH; Guan Y; Xia Y; Zhou X; Zhang D; Rook M; Vliegenthart R; Heuvelmans MA; Dorrius MD; van Ooijen PMA; Groen HJM; van der Harst P; Xiao Y; Ye Z; Xie X; Wang W; Oudkerk M; Fan L; Liu S
Acad Radiol; 2021 Jan; 28(1):36-45. PubMed ID: 32151538
[TBL] [Abstract][Full Text] [Related]
8. Evaluating other diseases with computed tomographic screening for lung cancer.
Wittig G
JAMA; 2013 Feb; 309(7):656. PubMed ID: 23423405
[No Abstract] [Full Text] [Related]
9. Evaluating other diseases with computed tomographic screening for lung cancer--reply.
Mets OM; de Jong PA; Prokop M
JAMA; 2013 Feb; 309(7):656-7. PubMed ID: 23423406
[No Abstract] [Full Text] [Related]
10. Thoracic CT screening: using routinely detectable COPD information.
Rizzo A; Mulshine JL
Clin Imaging; 2021 Oct; 78():310-312. PubMed ID: 34140204
[TBL] [Abstract][Full Text] [Related]
11. Screening for Lung Cancer: Incidental Pulmonary Parenchymal Findings.
Chung JH; Richards JC; Koelsch TL; MacMahon H; Lynch DA
AJR Am J Roentgenol; 2018 Mar; 210(3):503-513. PubMed ID: 29231759
[TBL] [Abstract][Full Text] [Related]
12. Evaluating other diseases with computed tomographic screening for lung cancer.
Huesch MD; Ong MK; Doctor JN
JAMA; 2013 Feb; 309(7):655-6. PubMed ID: 23423404
[No Abstract] [Full Text] [Related]
13. One Screening for Ischemic Heart Disease, Lung Cancer, and Chronic Obstructive Pulmonary Disease: A Systems Biology Bridge for Tobacco and Radiation Exposure.
Mulshine JL
Am J Public Health; 2018 Oct; 108(10):1294-1295. PubMed ID: 30207781
[No Abstract] [Full Text] [Related]
14. Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans.
Mets OM; Buckens CF; Zanen P; Isgum I; van Ginneken B; Prokop M; Gietema HA; Lammers JW; Vliegenthart R; Oudkerk M; van Klaveren RJ; de Koning HJ; Mali WP; de Jong PA
JAMA; 2011 Oct; 306(16):1775-81. PubMed ID: 22028353
[TBL] [Abstract][Full Text] [Related]
15. Beyond lung cancer: a strategic approach to interpreting screening computed tomography scans on the basis of mortality data from the National Lung Screening Trial.
Chiles C; Paul NS
J Thorac Imaging; 2013 Nov; 28(6):347-54. PubMed ID: 24071622
[TBL] [Abstract][Full Text] [Related]
16. Toward Automated Detection of Chronic Obstructive Pulmonary Disease in CT Lung Cancer Screening.
Vliegenthart R
Radiology; 2023 Jun; 307(5):e231350. PubMed ID: 37338359
[No Abstract] [Full Text] [Related]
17. Detection of chronic obstructive pulmonary disease in community-based annual lung cancer screening: Chiba Chronic Obstructive Pulmonary Disease Lung Cancer Screening Study Group.
Sekine Y; Fujisawa T; Suzuki K; Tsutatani S; Kubota K; Ikegami H; Isobe Y; Nakamura M; Takiguchi Y; Tatsumi K
Respirology; 2014 Jan; 19(1):98-104. PubMed ID: 24033868
[TBL] [Abstract][Full Text] [Related]
18. The potential impact of chronic obstructive pulmonary disease in lung cancer screening: implications for the screening clinic.
Young RP; Hopkins R
Expert Rev Respir Med; 2019 Aug; 13(8):699-707. PubMed ID: 31274043
[No Abstract] [Full Text] [Related]
19. Frequency of Incidental Findings and Subsequent Evaluation in Low-Dose Computed Tomographic Scans for Lung Cancer Screening.
Morgan L; Choi H; Reid M; Khawaja A; Mazzone PJ
Ann Am Thorac Soc; 2017 Sep; 14(9):1450-1456. PubMed ID: 28421812
[TBL] [Abstract][Full Text] [Related]
20. [Screening and prevention. Danish Society of Pulmonary Medicine].
Tønnesen P; Dirksen A
Ugeskr Laeger; 2005 Mar; 167(12-13):1395. PubMed ID: 15832715
[No Abstract] [Full Text] [Related]
[Next] [New Search]
